US/EU trade, investment 'big deal' pact could serve biopharma well
This article was originally published in Scrip
Executive Summary
Plans to launch negotiations between the US and the European Union aimed at forming a comprehensive trade and investment pact – first revealed by President Barack Obama during his 12 February State of the Union address – was welcomed by groups representing the biopharmaceutical industry, which said sealing such an agreement would be a positive move for drug makers in those territories.